Skip to main content
Tech Funding News· Sofia Chesnokova·· 8 days agoTop DealsAI Score65

SRTD Biotech raises €31.5M seed for marker-triggered RNA therapies

Why Lilly and Boehringer backed a German startup’s mRNA ‘on-off switch’ in a €31.5M seed

AI Overview

SRTD Biotech, a German startup founded in 2019, raised an oversubscribed €31.5M seed round co-led by Mérieux Equity Partners and NRW.BANK.

Why it matters

The round shows how pharma venture arms are backing RNA designs that activate only in diseased cells, and it sets that against larger US competitors and a flat mRNA market forecast.

Source:Tech Funding News · techfundingnews.com

Subscribe to the newsletters

Free, by email. No account needed. Pick one or both.

No spam. Unsubscribe anytime by emailing team@midu.si. Want alerts and full data? Sign up free (separate from the newsletter). Privacy.

Not investment advice. Midu summarizes public reports and SEC filings for information only. · Free API · Pricing